Metabolic and Antioxidant Status, Telomere Lengths of Individuals With Prediabetes in Context of 3 Months of Insoluble Dietary Fibre Intake During the SARS ‐ CoV2 Pandemic
Endocrinology, Diabetes & Metabolism · 2026-05 · 9 (3)
DOI: 10.1002/edm2.70210 ↗At a glance
Klinische Studie (Phase II) in Endocrinology, Diabetes & Metabolism, published online on 2026-03-27. Written by Mykola Khalangot and 7 co-authors. Institution: Komisarenko Institute of Endocrinology and Metabolism, Kyiv, Ukraine. Major MEDLINE topics: Antioxidants, COVID-19, Dietary Fiber, Prediabetic State. 25 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Research Foundation of Ukraine.
Abstract (original language)
Background
Insoluble fibre (IF) may reduce the risk factors of type 2 diabetes development, but evidence on its short‐term effects is limited. The influence of IF on oxidative stress markers, including reduced glutathione (GSH) and antioxidant enzymes, as well as on leukocyte telomere length (LTL), remains poorly studied. Coronavirus disease (COVID‐19) occurring before or during IF interventions may influence study outcomes.
Methods
The study included 29 adults with impaired fasting glucose (IFG) who received 15 g/day of IF for 3 months. Seven participants had a recent history of COVID‐19, defined as PCR‐confirmed infection within 6 months before the intervention or COVID‐19‐like symptoms during the study. Fasting plasma glucose, 2‐h plasma glucose (2hPG) during a WHO oral glucose tolerance test, glycated haemoglobin (HbA1c) and GSH were assessed at baseline and after 3 months. Fat mass (FM), blood pressure (BP), LTL, superoxide dismutase and catalase (CAT) were also measured.
Results
In participants without COVID‐19 ( n = 22), IF intake was associated with reductions in 2hPG, HbA1c, FM and GSH, along with an increase in systolic BP. In the COVID‐19 group ( n = 7), HbA1c decreased, while both systolic and diastolic BP increased. No significant changes in LTL, superoxide dismutase or CAT levels were observed in either group.
Conclusion
Short‐term IF supplementation in individuals with IFG improved selected glycaemic parameters but was accompanied by unexpected reductions in GSH and increases in blood pressure. These findings indicate complex physiological responses to IF that warrant further investigation. Trial Registration ClinicalTrials.gov identifier: NCT04283201
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Komisarenko Institute of Endocrinology and Metabolism, Kyiv, Ukraine.
- Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine.
- Chebotariov Institute of Gerontology, Kyiv, Ukraine.
- Bohomolets National Medical University, Kyiv, Ukraine.
- Karazin Kharkiv National University, Kharkiv, Ukraine.
ORCID profiles: Mykola Khalangot, Dmytro Krasnienkov, Vitaliy Gurianov, Tamara Zakharchenko, Olexiy Barsukov, Kostiantyn Midlovets, Victor Kravchenko, Mykola Tronko
Funding
- National Research Foundation of Ukraine
Cite
APA
Khalangot, M., Krasnienkov, D., Gurianov, V., Zakharchenko, T., Barsukov, O., Midlovets, K., Kravchenko, V., & Tronko, M. (2026). Metabolic and Antioxidant Status, Telomere Lengths of Individuals With Prediabetes in Context of 3 Months of Insoluble Dietary Fibre Intake During the SARS ‐ CoV2 Pandemic. Endocrinology, Diabetes & Metabolism, 9(3). https://doi.org/10.1002/edm2.70210
Vancouver
Khalangot M, Krasnienkov D, Gurianov V, Zakharchenko T, Barsukov O, Midlovets K, et al. Metabolic and Antioxidant Status, Telomere Lengths of Individuals With Prediabetes in Context of 3 Months of Insoluble Dietary Fibre Intake During the SARS ‐ CoV2 Pandemic. Endocrinology, Diabetes & Metabolism. 2026;9(3). doi:10.1002/edm2.70210
BibTeX
@article{Khalangot2026,
author = {Khalangot, Mykola and Krasnienkov, Dmytro and Gurianov, Vitaliy and Zakharchenko, Tamara and Barsukov, Olexiy and Midlovets, Kostiantyn and Kravchenko, Victor and Tronko, Mykola},
title = {Metabolic and Antioxidant Status, Telomere Lengths of Individuals With Prediabetes in Context of 3 Months of Insoluble Dietary Fibre Intake During the SARS ‐ CoV2 Pandemic},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2026},
volume = {9},
number = {3},
doi = {10.1002/edm2.70210}
}
EUVIMED